DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Hillery CA, Mancuso DJ, Evan Sadler J. et al.
Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.

Blood 1998;
91 (05) 1572-1581

Download Bibliographical Data

Access:
Access: